MedTrace Logo

Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study

NCT07332260 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-04-22

No results posted yet for this study

Summary

The goal of this study is to assess the feasibility and safety of faecal microbiota transplantation for Alzheimer's disease.

Conditions

  • Alzheimer s Disease
  • Faecal Microbiota Transplantation (FMT)

Interventions

BIOLOGICAL

Biological: Preprocessed thawed donor FMT

Biological: Preprocessed FMT solution is administered to the right side of the colon during a colonoscopy.

Sponsors & Collaborators

  • UiT The Arctic University of Norway

    collaborator OTHER

  • University Hospital of North Norway

    lead OTHER

Principal Investigators

  • Mona Dixon Gundersen, MBChB, PhD · University Hospital of North Norway, Tromsø

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2026-10-31
Completion
2027-01-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07332260 on ClinicalTrials.gov